NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Shares in health care IT company Allscripts soar amid strong outlook

Published 07/16/2015, 07:00 PM
Updated 07/16/2015, 07:05 PM
Health care IT company Allscripts said Thurs it expects to beat forecasts with its 2Q earnings
MDRX
-

Investing.com -- Shares in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) surged by more than 10% in after-hours trading on Thursday, after the health care information technology company offered preliminary second quarter earnings slightly ahead of analysts' forecasts.

Bolstered by a $233 million increase in bookings on a year-over-year basis, Allscripts expects to earn revenues of $350 to $353 million for the period or 0.12 per share. The projections are slightly above analysts' forecasts of $347.4 million in revenues or earnings per share of 0.10.

Founded in 1986 in Chicago, Allscripts provides physician practices, hospitals and other healthcare practices with practice management tools and electronic health record technology. The company services more than 180,000 physicians and has technology systems in place in approximately 2,700 hospitals in the U.S.

Over the last eight years, Allscripts has grown exponentially following acquisitions of rival Misys in 2008 and Eclipsys in 2010.

"Our strong preliminary results across all key financial metrics reflect continued improvement in Allscripts execution across the enterprise on behalf of our clients," CEO Paul M. Black said in a statement. "Sales growth in the second quarter accelerated compared with the first quarter based on improving performance within acute and international markets. Ambulatory solutions and growth in Allscripts payer and life sciences business helped drive the year-over-year bookings growth."

Shares in Allscripts jumped by 1.46 or 10.72% in after-hours to 13.62. The company will release its second quarter earnings after the close of markets on Aug. 4.

"Revenue improved on a sequential basis, driven by growth in both recurring and non-recurring revenue," Black added. "We look forward to discussing our results in more detail in a few weeks."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.